Form 4/A Viking Therapeutics, For: Aug 25 Filed by: LIGAND PHARMACEUTICALS INC

Go back to Form 4/A Viking Therapeutics, For: Aug 25 Filed by: LIGAND PHARMACEUTICALS INC
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 5.85 +0.15 (2.63%)
Previous Close $5.70    52 Week High $5.17 
Open $5.91    52 Week Low $0.94 
Day High $6.03    P/E N/A 
Day Low $5.83    EPS $0.00 
Volume 682,302